POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA IN THE REAL WORLD. (17th June 2021) - Vodicka, P; Benesova, K; Janikova, A; Prochazka, V; Belada, D; Mocikova, H; Steinerova, K; Duras, J; Karban, J; Hanackova, V; Sykorova, A; Obr, A; et al.